Glutathione Therapy

Increase of reduced Glutathione (GSH) with GlutCell glutathione, a sulphurous Tripeptide, is responsible in its reduced form (GSH) for almost all of the self-healing – and protection mechanisms in the body. Low glutathione levels can be observed in almost all chronic diseases. This has the consequence, that basic, necessary for healing (immune) functions not or inadequately can expire. Increase the glutathione levels has proved as gentle, highly effective Basistheraphie, especially for viral infections, rheumatism, cancer, AIDS, and she increased in recent times to observational complex – or multi system diseases, such as about the chronic Lyme disease and chronic fatigue syndrome (CFS). Therapeutic approach as glutathione in capsule form under the current studies no clinically relevant effects achieved by let undGlutathion infusions due to lack of German approval from Italy imported must be, was a medical-Nutrition approach from German research selected. The preparation of (GlutCell) combines the central part of glutathione, the sulfur-containing amino acid cysteine, vitamin C and a special treatment of secondary plant compounds (polyphenols).

This active ingredient composition (GSH-intra) designed for the promotion of glutathione-formation in the body’s cells. The combined approach, the organism with a central part of glutathione cysteine to supply and to promote the formation of glutathione within cells, at the same time by the manufacturer in the context of observational GSH-intra examines methods. The participating patient (female, born 1969) suspected the existence of a chronified Lyme disease a capsule awarded over 14 days of nutrient combination GlutCell. Before and after taking investigated their levels of reduced glutathione within the most important immune cells, lymphocytes, monocytes and natural killer cell (NK cells). The determination of intracellular glutathione levels was carried out by the Institute for medical Diagnosis in Berlin (www.imd-berlin.de). Initial – and final findings were released by Dr. Volker von Baehr. The patient of reduced glutathione in the cells by more than 400% increase was observed results.

All figures who were humiliated in the initial investigation, were the final examination in the upper normal range. Overall were observed following increases: (values for the author) lymphocytes: by 111 on 791 mfi monocytes: 174 NK cells mfi on 673: mfi from 261 on 1084 contact LuxXPharma s.a. 13, Wuelesser wee l 9838 Eisenbach Luxembourg + 352 26903921 fax + 352 24611162 press contact: QvorQ GmbH & co. KG on the high way 10 27313 Dorverden Tel.: + 49 (0) 4234 94136 fax: + 49 (0) 94137 – 4234 E-Mail: Web: